Evidence map›Paper›PMID 30415511›Full record

ArticleJournal of biomedical optics2018

Correcting Cherenkov light attenuation in tissue using spatial frequency domain imaging for quantitative surface dosimetry during whole breast radiation therapy.

Rachael Hachadorian, Petr Bruza, Michael Jermyn, Amaan Mazhar, David Cuccia, Lesley Jarvis, David Gladstone, Brian Pogue

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Real-time motion tracking of a gold implant in water by Cherenkov lights.Journal of applied clinical medical physics · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Imaging and characterization of optical emission fromPhysics in medicine and biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Color Cherenkov imaging of clinical radiation therapy.Light, science & applications · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Rachael HachadorianDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Petr BruzaDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Michael JermynDoseOptics LLC, Lebanon, New Hampshire, United States.
Amaan MazharModulated Imaging Inc., Irvine, California, United States.
David CucciaModulated Imaging Inc., Irvine, California, United States.
Lesley JarvisDartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States.
David GladstoneDartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States.
Brian PogueDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Dartmouth College · USModulim (United States) · USUSC Norris Comprehensive Cancer Center · USCotton (United States) · USDoseOptics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imaging Cherenkov emission during radiotherapy permits real-time visualization of external beam delivery on superficial tissue. This signal is linear with absorbed dose in homogeneous media, indicating potential for quantitative dosimetry. In humans, the inherent heterogeneity of tissue optical properties (primarily from blood and skin pigment) distorts the linearity between detected Cherenkov signal and absorbed dose. We examine the potential to correct for superficial vasculature using spatial frequency domain imaging (SFDI) to map tissue optical properties for large fields of view. In phantoms, applying intensity corrections to simulate blood vessels improves Cherenkov image (CI) negative contrast by 24% for a vessel 1.9-mm-in diameter. In human trials, SFDI and CI are acquired for women undergoing whole breast radiotherapy. Applied corrections reduce heterogeneity due to vasculature within the sampling limits of the SFDI from a 22% difference as compared to the treatment plan, down to 6% in one region and from 14% down to 4% in another region. The optimal use for this combined imaging system approach is to correct for small heterogeneities such as superficial blood vessels or for interpatient variations in blood/melanin content such that the corrected CI more closely represents the surface dose delivered.

Indexed as

Breast NeoplasmsSignal Processing, Computer-AssistedBreastEquipment DesignFemaleHumansImage Interpretation, Computer-AssistedPhantoms, ImagingRadiometryCherenkovimagingradiation therapyspatial frequency domain imagingtissue optics

Identifiers

PMID30415511
PMCPMC6228320
OpenAlexW2900021895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.